The 2nd NSCLC Drug Development Summit is the only industry-led forum for large bio-pharma, biotech, and academic leaders to address mechanisms of drug resistance, spearhead progress in molecular subtyping, and define practice-changing drug sequencing and combinations for the largest solid tumor indication.